Showing 2021-2030 of 5643 results for "".
- Oculis Raises $15.7 Million to Advance Development of Novel Topical Treatments for Ophthalmic Diseaseshttps://modernod.com/news/oculis-raises-15-7-million-to-advance-development-of-novel-topical-treatments-for-ophthalmic-diseases/2476221/Oculis announced that it has successfully raised a further 15.5 million Swiss Franc ($15.7 million) in an extension of its Series B financing round, announced in January 2018, bringing the total raised to 35.5 million Swiss Franc. The extension round was led by funds managed by Tekla Capital Mana
- ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2https://modernod.com/news/proqr-receives-fast-track-designation-from-fda-for-qr-421a-for-usher-syndrome-type-2/2476227/ProQR Therapeutics announced that it received Fast Track designation from the FDA for QR-421a, a first-in-class investigational RNA-based oligonucleotide designed to address the underlying cause of the vision loss associated with Usher syndrome type 2 and non-syndromic retinitis pigmentosa (RP) d
- Beaver-Visitec International to Acquire PhysIOL Grouphttps://modernod.com/news/tpg-capital-backs-bvi-to-acquire-physiol-group-sa/2476246/Beaver-Visitec International (BVI) announced it has signed a definitive agreement to acquire PhysIOL Group, a Belgium-based ophthalmic company specializing in the research, development, and manufacture of IOLs, from TA Associates. Financial terms of the transaction were not disclosed.
- Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based OCT Closer to Markethttps://modernod.com/news/notal-vision-engages-wasatch-photonics-bringing-ai-enabled-home-based-oct-closer-to-market/2479605/Notal Vision has announced the achievement of a significant milestone in its plan to develop and commercialize a home-based, patient-operated, spectral-domain optical coherence tomography (SD-OCT) system. The first targeted application of the Notal Home OCT is to monitor wet age-related macular d
- FDA Clears First Daily Disposable Silicone Hydrogel Contact Lens Coated with Modified Formula of Tangible Hydra-PEGhttps://modernod.com/news/fda-clears-first-daily-disposable-silicone-hydrogel-contact-lens-coated-with-modified-formula-of-tangible-hydra-peg/2479611/Tangible Science announced that the FDA has cleared the first daily disposable silicone hydrogel contact lens coated with a modified formula of Tangible Hydra-PEG. Tangible Hydra-PEG is an innovative coating applied to custom contact lenses to improve lens wettability and deposit resistanc
- RetinaLyze Receives Funding to Detect Diseases Such as Alzheimer’s Using AIhttps://modernod.com/news/retinalyze-receives-funding-to-detect-diseases-such-as-alzheimers-using-ai/2479612/RetinaLyze System A/S (Ltd.), a Denmark-based medical technology company that specializes in retinal imaging screening software, has received funding from The European Regional Development Fund (ERDF) and Central Denmark Region. The funding will be used to explore and develop novel AI-based solut
- RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disordershttps://modernod.com/news/retipharma-secures-funding-to-develop-treatments-of-degenerative-eye-disorders/2479680/RetiPharma has announced that it has secured funding from the Novo Nordisk Foundation’s BioInnovation Institute (BII). The funding will be used to prepare its lead drug RP001 for a clinical proof-of-concept study in patients with retinal detachment as well as to in source additional compounds usi
- Calcified Nodules Linked to AMD Progressionhttps://modernod.com/news/calcified-nodules-linked-to-amd-progression/2479682/The presence of a specific type of calcified nodule in the retinal drusen of patients with age-related macular degeneration (AMD) is associated with a more than sixfold increased risk for late-stage progression of the disease, a study has shown, according to a Medscape
- Evidence Mounts That an Eye Scan May Detect Early Alzheimer’s Diseasehttps://modernod.com/news/evidence-mounts-that-an-eye-scan-may-detect-early-alzheimers-disease/2479725/Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer’s. Even patients who have a family histo
- Clerio Vision: First Noninvasive Laser Vision Correction Procedures Performedhttps://modernod.com/news/clerio-vision-first-noninvasive-laser-vision-correction-procedures-performed/2479743/Leveraging technology developed at the University of Rochester that was recently recognized with a Nobel Prize, Clerio Vision is commercializing LIRIC—a novel, noninvasive method to correct human vision. The core technology has been in development for more than 15 year